Dr. Ingenito is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis Street
Ca 318 Brigham And Womens Hospital Pulmonary Division
Boston, MA 02115Phone+1 617-732-7420
Education & Training
- Brigham and Women's HospitalResidency, Internal Medicine, 1984 - 1987
- Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1984
- Harvard Medical SchoolClass of 1982
Certifications & Licensure
- MA State Medical License 1986 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 10 citationsTranscutaneous carbon dioxide in severe COPD patients during bronchoscopic lung volume reduction.Oren Fruchter, Uri Carmi, Edward P. Ingenito, Yeal Refaeli, Mordechai R. Kramer
Respiratory Medicine. 2011-04-01 - 341 citationsTezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic FibrosisSteven M. Rowe, Cori L. Daines, Felix C. Ringshausen, Eitan Kerem, John W Wilson
The New England Journal of Medicine. 2017-11-03 - 197 citationsTezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.Jennifer L Taylor-Cousar, Anne Munck, Edward F McKone, Cornelis K van der Ent, Alexander Moeller
The New England Journal of Medicine. 2017-11-23
Grant Support
- Pneumografting - A Novel Cell-Based Therapy For EmphysemaNational Heart, Lung, And Blood Institute2007–2010
- Pneumoreductive Surfactant Therapy For EmphysemaNational Heart, Lung, And Blood Institute2007
- Pneumoreductive Surfactant Therapy For EmphysemaNational Heart, Lung, And Blood Institute2006–2007
- Force Propagation Of Emphysema In VivoNational Heart, Lung, And Blood Institute2004–2007
- Responses To Surgical And Bronchoscopic Volume ReductionNational Heart, Lung, And Blood Institute2002–2006
- Free Radical Induced Surfactant Dysfunction In Acute Lung InjuryNational Heart, Lung, And Blood Institute1996–2005
- Pneumedoreductive Surfacant - New Therapy For EmphysemaNational Heart, Lung, And Blood Institute2004
- Free Radical Induced Surfactant Dysfunction In Acute Lung InjuryNational Heart, Lung, And Blood Institute1996–2002
- Lung Volume Reduction Using A Bronchoscopic ApproachNational Heart, Lung, And Blood Institute1999–2000
- Determinants Of Tissue ResistanceNational Heart, Lung, And Blood Institute1993–1995
- Determinants Of Tissue Resistance In The Guinea PIGNational Heart, Lung, And Blood Institute1991–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: